-
Oct 31, 2024 | 
dailyitem.com | Abbott Laboratories
Abbott Laboratories recently began selling its new Lingo device, a continuous glucose monitor that's available without a prescription. It's part of a larger trend where companies are increasingly promoting wearable devices aimed at people interested in improving their health and wellness. (Abbott Laboratories/TNS)
-
Aug 27, 2024 | 
academic.oup.com | Abbott Laboratories |Abbott Park |KU Leuven
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne Phlebovirus (Liu et al. 2014), first identified in China in 2009 (Yu et al. 2011), that has since rapidly spread to several neighboring East Asian countries (Takahashi et al. 2013; Kim et al. 2018; Tran et al. 2019; Win et al. 2020; Rattanakomol et al. 2022). Clinically, the virus induces an elevated and prolonged fever (22.5 ± 7.6 days) accompanied by thrombocytopenia (Luo et al. 2023), gastrointestinal distress (Akagi et al.
-
Jul 8, 2024 | 
academic.oup.com | Xiao Yan |Abbott Laboratories |Abbott Park |Pow Lee
The objective of this study was to compare The Binding Site’s Freelite on Optilite and Diazyme’s Kappa/Lambda free light chains (K/L FLC) on Abbott Architect c8000 with healthy and renal insufficient populations and to evaluate their respective reference intervals for serum free light chains (sFLCs). Two hundred sixty serum samples were measured for creatinine and sFLCs by both assays and a subset by immunofixation electrophoresis.
-
May 9, 2024 | 
uk.investing.com | Abbott Laboratories
Benzinga - by Avi Kapoor, Benzinga Staff Writer. The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
-
Apr 17, 2024 | 
uk.investing.com | Abbott Laboratories
Benzinga - by Avi Kapoor, Benzinga Staff Writer. With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:Wall Street expects Abbott Laboratories (NYSE: ABT) to report quarterly earnings at 95 cents per share on revenue of $9.88 billion before the opening bell, according to data from Benzinga Pro. Abbott shares gained 1% to $110.30 in after-hours trading. Intra-Cellular Therapies, Inc.
-
Jan 16, 2024 | 
uk.investing.com | Abbott Laboratories
© Reuters. Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'Benzinga - by Avi Kapoor, Benzinga Staff Writer. On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named Crown Castle Inc. (NYSE: CCI)as her final trade. Crown Castle, last month, announced a comprehensive review of its Fiber business and the addition of two new independent directors to the company's board.
-
Jan 12, 2024 | 
uk.investing.com | Abbott Laboratories
© Reuters. Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'Benzinga - by Avi Kapoor, Benzinga Staff Writer. On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. (NYSE: UBER) shares hit an all-time high on Thursday above the Feb. 2021 high. He remains long on the stock and still loves it. Goldman Sachs analyst Eric Sheridan maintained Uber Technologies with a Buy and raised the price target from $59 to $78.
-
Oct 10, 2023 | 
investing.com | Abbott Laboratories
EditorRachael RajanStock MarketsPublished Oct 10, 2023 01:39PM ET Abbott Laboratories (NYSE:), American Financial Group Inc (NYSE:), and Bank OZK (NASDAQ:) are scheduled to trade ex-dividend on Thursday, October 12, 2023. This comes as part of Dividend Channel's coverage and is expected to impact their opening prices due to recent stock price movements. On Tuesday, all three stocks experienced an uptick in trading.
-
Sep 29, 2023 | 
uk.investing.com | Abbott Laboratories
Stock MarketsPublished Sep 29, 2023 13:53Updated Sep 29, 2023 15:10© Reuters. Abbott Laboratories And More On CNBC's 'Final Trades'Benzinga - by Priya Nigam, Benzinga Staff Writer. On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S. Equity Power Buffer ETF October (NYSE: POCT) as her final trade. Stephen Weiss of Short Hills Capital Partners picked U.S. 10 Year Treasury Note .
-
Jun 11, 2023 | 
marketwatch.com | Abbott Laboratories |Abbott Park
The MarketWatch News Department was not involved in the creation of this content. (EDGAR Online via COMTEX) -- 0000001800 false Common Shares, Without Par Value ABT 0000001800 2023-06-09 2023-06-09 0000001800 us-gaap:CommonStockMember exch:XCHI 2023-06-09 2023-06-09 0000001800 us-gaap:CommonStockMember exch:XNYS 2023-06-09 2023-06-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Common Shares, Without Par Value ABT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C.
